Zhou W - Search Results

1

Discovery of degradable niclosamide derivatives able to specially inhibit small cell lung cancer (SCLC).

He X, Li M, Ye W, Zhou W. He X, et al. Among authors: zhou w. Bioorg Chem. 2021 Feb;107:104574. doi: 10.1016/j.bioorg.2020.104574. Epub 2020 Dec 28. Bioorg Chem. 2021. PMID: 33383327

2

Semi-synthesis and anti-tumor activity of 5,8-O-dimethyl acylshikonin derivatives.

Zhou W, Peng Y, Li SS. Zhou W, et al. Eur J Med Chem. 2010 Dec;45(12):6005-11. doi: 10.1016/j.ejmech.2010.09.068. Epub 2010 Oct 7. Eur J Med Chem. 2010. PMID: 20970893

3

Semi-synthesis and antitumor activity of 6-isomers of 5, 8-O-dimethyl acylshikonin derivatives.

Zhou W, Zhang X, Xiao L, Ding J, Liu QH, Li SS. Zhou W, et al. Eur J Med Chem. 2011 Aug;46(8):3420-7. doi: 10.1016/j.ejmech.2011.05.006. Epub 2011 May 12. Eur J Med Chem. 2011. PMID: 21620530

4

Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.

Cui J, Meng Q, Zhang X, Cui Q, Zhou W, Li S. Cui J, et al. Among authors: zhou w. J Med Chem. 2015 Apr 23;58(8):3534-47. doi: 10.1021/acs.jmedchem.5b00265. Epub 2015 Apr 1. J Med Chem. 2015. PMID: 25799264

5

Design and synthesis of structurally defined heparan sulfate (HS)-FK506 conjugates as an exogenous approach to investigate biological functions of nucleus HS.

Li M, Yuan S, Chen J, Lv L, Guo S, Zhou W. Li M, et al. Among authors: zhou w. Bioorg Chem. 2018 Dec;81:203-210. doi: 10.1016/j.bioorg.2018.08.015. Epub 2018 Aug 16. Bioorg Chem. 2018. PMID: 30144633

6

Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.

Zhou L, Chen W, Cao C, Shi Y, Ye W, Hu J, Wang L, Zhou W. Zhou L, et al. Among authors: zhou w. Eur J Med Chem. 2020 Mar 1;189:112028. doi: 10.1016/j.ejmech.2019.112028. Epub 2020 Jan 2. Eur J Med Chem. 2020. PMID: 31945665

7

Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances.

Fu K, Bai Z, Chen L, Ye W, Wang M, Hu J, Liu C, Zhou W. Fu K, et al. Among authors: zhou w. Eur J Med Chem. 2020 May 1;193:112221. doi: 10.1016/j.ejmech.2020.112221. Epub 2020 Mar 14. Eur J Med Chem. 2020. PMID: 32222663 Review.

8

Oligosaccharide-camptothecin conjugates as potential antineoplastic drugs: Design, synthesis and biological evaluation.

Li M, Ye W, Fu K, Zhou C, Shi Y, Huang W, Chen W, Hu J, Jiang Z, Zhou W. Li M, et al. Among authors: zhou w, zhou c. Eur J Med Chem. 2020 Sep 15;202:112509. doi: 10.1016/j.ejmech.2020.112509. Epub 2020 Jun 30. Eur J Med Chem. 2020. PMID: 32668379

9

Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies.

Wang M, Chen W, Chen J, Yuan S, Hu J, Han B, Huang Y, Zhou W. Wang M, et al. Among authors: zhou w. Eur J Med Chem. 2021 Aug 5;220:113487. doi: 10.1016/j.ejmech.2021.113487. Epub 2021 Apr 23. Eur J Med Chem. 2021. PMID: 33933752 Review.

10

α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship.

Chen P, Wang S, Cao C, Ye W, Wang M, Zhou C, Chen W, Zhang X, Zhang K, Zhou W. Chen P, et al. Among authors: zhou w, zhou c. Bioorg Chem. 2021 Nov;116:105295. doi: 10.1016/j.bioorg.2021.105295. Epub 2021 Aug 21. Bioorg Chem. 2021. PMID: 34455300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,048 results

Search Page

Filters